Cargando…
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
INTRODUCTION: Immunotherapy may be an excellent choice for treating osteosarcoma given its exceptionally high genomic instability, potentially generating neoantigens. In this study, we aim to investigate the HLA class I expression, PD-L1 and tumour-infiltrating lymphocytes in primary osteosarcomas a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222929/ https://www.ncbi.nlm.nih.gov/pubmed/27853827 http://dx.doi.org/10.1007/s00262-016-1925-3 |
_version_ | 1782493084498526208 |
---|---|
author | Sundara, Yayan T. Kostine, Marie Cleven, Arjen H. G. Bovée, Judith V. M. G. Schilham, Marco W. Cleton-Jansen, Anne-Marie |
author_facet | Sundara, Yayan T. Kostine, Marie Cleven, Arjen H. G. Bovée, Judith V. M. G. Schilham, Marco W. Cleton-Jansen, Anne-Marie |
author_sort | Sundara, Yayan T. |
collection | PubMed |
description | INTRODUCTION: Immunotherapy may be an excellent choice for treating osteosarcoma given its exceptionally high genomic instability, potentially generating neoantigens. In this study, we aim to investigate the HLA class I expression, PD-L1 and tumour-infiltrating lymphocytes in primary osteosarcomas and relapses/metastases, as well as their changes during disease progression. MATERIALS AND METHODS: Tumour samples from multiple stages of the disease (pretreatment biopsies, surgical resections of primary osteosarcomas, relapses and metastases) were collected and stained for HLA-A (HCA2), HLA-B/C (HC10), β2-microglobulin and PD-L1 using immunohistochemistry on whole sections. Density and type of T-cell infiltrate were characterised by a triple immunofluorescent staining CD3-CD8-FOXP3. RESULTS: Overall, 85 formalin-fixed, paraffin-embedded blocks from 25 osteosarcoma patients were included. HLA class I expression was detected in 94% of osteosarcomas (strongly positive in 56%, heterogeneous in 38%) and negative or weakly positive in 6%, without differences between the stages of the disease. HLA-A expression was more frequently negative than HLA-B/C. Tumour-infiltrating lymphocytes were highly heterogeneous and mainly observed in tumour areas with expression of HLA class I. Density of T cells was significantly higher in metastases than in primary tumours and local relapses (p = 0.0003). Positive PD-L1 expression was found in 13% of primary tumours, 25% of relapses and 48% of metastases and correlated with a high T-cell infiltrate (p = 0.002). CONCLUSION: An increased number of tumour-infiltrating T cells and PD-L1 expression in metastases compared with primary tumours, suggesting accessibility for T cells, could imply that osteosarcoma patients with metastatic disease may benefit from T-cell-based immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-016-1925-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5222929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-52229292017-01-19 Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy Sundara, Yayan T. Kostine, Marie Cleven, Arjen H. G. Bovée, Judith V. M. G. Schilham, Marco W. Cleton-Jansen, Anne-Marie Cancer Immunol Immunother Original Article INTRODUCTION: Immunotherapy may be an excellent choice for treating osteosarcoma given its exceptionally high genomic instability, potentially generating neoantigens. In this study, we aim to investigate the HLA class I expression, PD-L1 and tumour-infiltrating lymphocytes in primary osteosarcomas and relapses/metastases, as well as their changes during disease progression. MATERIALS AND METHODS: Tumour samples from multiple stages of the disease (pretreatment biopsies, surgical resections of primary osteosarcomas, relapses and metastases) were collected and stained for HLA-A (HCA2), HLA-B/C (HC10), β2-microglobulin and PD-L1 using immunohistochemistry on whole sections. Density and type of T-cell infiltrate were characterised by a triple immunofluorescent staining CD3-CD8-FOXP3. RESULTS: Overall, 85 formalin-fixed, paraffin-embedded blocks from 25 osteosarcoma patients were included. HLA class I expression was detected in 94% of osteosarcomas (strongly positive in 56%, heterogeneous in 38%) and negative or weakly positive in 6%, without differences between the stages of the disease. HLA-A expression was more frequently negative than HLA-B/C. Tumour-infiltrating lymphocytes were highly heterogeneous and mainly observed in tumour areas with expression of HLA class I. Density of T cells was significantly higher in metastases than in primary tumours and local relapses (p = 0.0003). Positive PD-L1 expression was found in 13% of primary tumours, 25% of relapses and 48% of metastases and correlated with a high T-cell infiltrate (p = 0.002). CONCLUSION: An increased number of tumour-infiltrating T cells and PD-L1 expression in metastases compared with primary tumours, suggesting accessibility for T cells, could imply that osteosarcoma patients with metastatic disease may benefit from T-cell-based immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-016-1925-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-11-16 2017 /pmc/articles/PMC5222929/ /pubmed/27853827 http://dx.doi.org/10.1007/s00262-016-1925-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Sundara, Yayan T. Kostine, Marie Cleven, Arjen H. G. Bovée, Judith V. M. G. Schilham, Marco W. Cleton-Jansen, Anne-Marie Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy |
title | Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy |
title_full | Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy |
title_fullStr | Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy |
title_full_unstemmed | Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy |
title_short | Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy |
title_sort | increased pd-l1 and t-cell infiltration in the presence of hla class i expression in metastatic high-grade osteosarcoma: a rationale for t-cell-based immunotherapy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222929/ https://www.ncbi.nlm.nih.gov/pubmed/27853827 http://dx.doi.org/10.1007/s00262-016-1925-3 |
work_keys_str_mv | AT sundarayayant increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy AT kostinemarie increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy AT clevenarjenhg increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy AT boveejudithvmg increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy AT schilhammarcow increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy AT cletonjansenannemarie increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy |